Ascend amlodipine/olmesartan tablets recalled for failed dissolution
Ascend Laboratories is recalling one lot of amlodipine and olmesartan medoxomil combination tablets (10 mg/20 mg) because the olmesartan medoxomil active ingredient is below the required amount. This means affected tablets may not work as intended to lower blood pressure.
From the FDA notice · Read the official notice ↗ · All Ascend Laboratories recalls
What to do
- Check if your amlodipine-olmesartan tablets are from lot 25121311 (expiration 3/31/2028).
- Contact your pharmacy or doctor if you have this lot — do not stop taking your blood pressure medication without medical guidance.
- Your pharmacist or doctor can provide a replacement or alternative medication.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 6,192 bottles
- Illnesses reported
- None reported
- Manufactured in
- 135 Us Highway 202 206 Ste 15, N/A, Bedminster, NJ, United States
- Classification
- Class II
- Recall number
- D-0712-2026
In the FDA's words
- Description
- Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30 Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications Lot 25121311, expiry 3/31/2028 Distribution: Nationwide in the USA Affected quantity: 6,192 bottles
- Hazard
- Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
More from Ascend Laboratories
See all- Ascend amlodipine/olmesartan tablets recalled for failed dissolution
ModerateFDAOct 16, 2026